Q3 2020 Processa Pharmaceuticals Inc Earnings Call Transcript
Good day, everyone, and welcome to the Processa Pharmaceuticals business update. (Operator Instructions)
It is now my pleasure to turn today's program over to Jim Stanker. Please go ahead, sir.
Thank you, operator. With me on our first earnings call are Dr. David Young, our Chief Executive Officer; Mike Floyd, our Chief Operating Officer; Dr. Sian Bigora, our Chief Development Officer; Wendy Guy, our Chief Administrative Officer; and Patrick Lin, our Chief Business and Strategy Officer.
Before we begin, I'd like to remind everyone that a PowerPoint presentation will accompany Dr. Young's prepared remarks. To review the PowerPoint slides, please go to the earnings press release and click on the webcast link to follow along.
Now I'd like to begin the call by reading the safe harbor statement. This statement is made pursuant to the safe harbor for forward-looking statements described in the Private Securities Litigation Reform Act of 1995. All statements made on this call, with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
